Gritstone Oncology, Inc. Common Stock, par value $0.0001 per share Underwriting AgreementUnderwriting Agreement • September 17th, 2018 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances) • New York
Gritstone Oncology, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representatives (the “Representatives”) an aggregate of [●] shares (the “Firm Shares”) and, at the election of the Underwriters, up to [●] additional shares (the “Optional Shares”) of common stock, par value $0.0001 per share (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
GRITSTONE ONCOLOGY, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • September 17th, 2018 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances) • Delaware
This Indemnification Agreement (this “Agreement”) is effective as of «Date» by and between Gritstone Oncology, Inc., a Delaware corporation (the “Company”), and «Indemnitee» (“Indemnitee”). This Agreement supersedes and replaces any and all previous agreements between the Company and the Indemnitee covering indemnification.
GRITSTONE ONCOLOGY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • September 17th, 2018 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”), entered into as of September 16, 2018 (the “Agreement Date”), is between Gritstone Oncology, Inc., a Delaware corporation (the “Company”) and Jayant Aphale (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as a binding contract as of the Agreement Date, but the operative provisions of this Agreement will only become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of February 9, 2018 (“Offer Letter”).
GRITSTONE ONCOLOGY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • September 17th, 2018 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”), entered into as of September 16, 2018 (the “Agreement Date”), is between Gritstone Oncology, Inc., a Delaware corporation (the “Company”) and Roman Yelensky (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as a binding contract as of the Agreement Date, but the operative provisions of this Agreement will only become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of September 22, 2015 (“Offer Letter”).
